As a key member of the BDD team, Dr. Pui Man Leung, with his appointment in April 2023, brings a wealth of experience and expertise to the forefront of pharmaceutical medicine.
Dr. Leung’s career, beginning with an MBChB from Aberdeen Medical School in 1989, has been marked by key roles in clinical research. His expertise was further recognized with a Diploma in Pharmaceutical Medicine in 2008 and entry onto the Specialist Register for Pharmaceutical Medicine in 2010. Prior to joining BDD Pharma, he was the Senior Director of Early Phase Research at MAC Clinical Research, leading significant advancements in early drug development.
At BDD, Dr. Leung’s focus is on leading first-in-human clinical trials and early-stage drug development. His extensive experience in various therapeutic areas is invaluable in driving innovative research strategies. Dr. Leung’s embrace of AI in drug development is set to revolutionize BDD Pharma’s approach to pharmaceutical research.
Dr. Leung’s vision for integrating AI and digital health technologies is pivotal for BDD Pharma’s future endeavours in pharmaceutical medicine. His leadership and strategic insights are crucial in navigating the complex landscape of drug development and clinical trials.
Dr. Pui Man Leung’s addition to the BDD team represents a significant step forward in our pursuit of innovation in pharmaceutical medicine. His expertise and forward-thinking approach are integral to the development of novel therapies and advancements in the field.
